Stock Events

Stock Events

Takeda Pharmaceutical 

$32.68
1165
+$0.43+1.33% Monday 13:30

Statistics

Day High
32.68
Day Low
32.68
52W High
37.83
52W Low
26.3
Volume
-
Avg. Volume
-
Mkt Cap
51.99B
P/E Ratio
71.67
Dividend Yield
1.97%
Dividend
0.64

Upcoming

25
JUN
Dividend Payment
Decreased
 
30
SEP
Dividend Ex
Increased
 
1
DEC
Dividend Payment
Increased
 
31
MAR 27
Dividend Ex
 
30
SEP 27
Dividend Ex
Estimated
 

Dividends

1.97%Dividend Yield
Dec 25
$0.68
Jun 25
$0.65
Dec 24
$0.68
Jun 24
$0.62
Dec 23
$0.63
10Y Growth
-2.79%
5Y Growth
-4.71%
3Y Growth
-0.83%
1Y Growth
-4.27%

Earnings

30JulExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
-0.44
-0.11
0.22
0.55
Expected EPS
0.37950297
Actual EPS
N/A

Financials

2.42%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
61.83BRevenue
1.5BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TKPHF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap146.36B
Pfizer is a global pharmaceutical company that competes with Takeda in various therapeutic areas, including oncology and immunology.
Novartis
NVS
Mkt Cap278.64B
Novartis is a multinational pharmaceutical company that competes directly with Takeda in areas such as cardiovascular, oncology, and neuroscience.
Merck
MRK
Mkt Cap275.09B
Merck is known for its strong presence in the pharmaceutical industry, competing with Takeda in oncology, vaccines, and infectious diseases.
Johnson & Johnson
JNJ
Mkt Cap532.77B
Johnson & Johnson, through its pharmaceutical segment Janssen, competes with Takeda in immunology, neuroscience, and oncology.
Abbvie
ABBV
Mkt Cap356.49B
AbbVie competes with Takeda in the fields of immunology and oncology, with both companies having significant investments in research and development.
GSK
GSK
Mkt Cap101.2B
GlaxoSmithKline competes with Takeda in respiratory, vaccines, and infectious disease, with a strong focus on research and development.
Sanofi
SNY
Mkt Cap103.76B
Sanofi competes with Takeda in areas such as immunology, oncology, and rare diseases, with a broad portfolio of products.
Bristol-Myers Squibb
BMY
Mkt Cap114.68B
Bristol Myers Squibb competes with Takeda in oncology and cardiovascular diseases, with both companies focusing on innovative treatments.
Roche
RHHBY
Mkt Cap329.06B
Roche, through its pharmaceutical division, competes with Takeda in oncology, immunology, and infectious diseases, with a strong emphasis on biologics.
Astrazeneca
AZN
Mkt Cap283.47B
AstraZeneca competes with Takeda in several key areas including oncology, cardiovascular, and respiratory diseases, with a focus on innovation and targeted therapies.

About

There is no Profile data available for TKD.SG.
Show more...
CEO
Mr. Christophe P. Weber
Employees
49281
Country
United States
ISIN
JP3463000004

Listings

MX
MX
TAKN.MX
MU
DE
TKDA.MU
STU
DE
TKD.STU
SA
BR
TAKP34.SA

0 Comments

Share your thoughts

FAQ

What is Takeda Pharmaceutical stock price today?▼
The current price of TKPHF is $32.68 USD — it has increased by +1.33% in the past 24 hours. Watch Takeda Pharmaceutical stock price performance more closely on the chart.
What is Takeda Pharmaceutical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Takeda Pharmaceutical stocks are traded under the ticker TKPHF.
Is Takeda Pharmaceutical stock price growing?▼
TKPHF stock has risen by +1.33% compared to the previous week, the month change is a -5.33% fall, over the last year Takeda Pharmaceutical has showed a +16.51% increase.
What is Takeda Pharmaceutical market cap?▼
Today Takeda Pharmaceutical has the market capitalization of 51.99B
When is the next Takeda Pharmaceutical earnings date?▼
Takeda Pharmaceutical is going to release the next earnings report on July 30, 2026.
What were Takeda Pharmaceutical earnings last quarter?▼
TKPHF earnings for the last quarter are -0.1 USD per share, whereas the estimation was -0.15 USD resulting in a +35.21% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Takeda Pharmaceutical revenue for the last year?▼
Takeda Pharmaceutical revenue for the last year amounts to 61.83B USD.
What is Takeda Pharmaceutical net income for the last year?▼
TKPHF net income for the last year is 1.5B USD.
Does Takeda Pharmaceutical pay dividends?▼
Yes, TKPHF dividends are paid semi-annual. The last dividend per share was 0.68 USD. As of today, Dividend Yield (FWD)% is 1.97%.
How many employees does Takeda Pharmaceutical have?▼
As of May 17, 2026, the company has 49,281 employees.
In which sector is Takeda Pharmaceutical located?▼
Takeda Pharmaceutical operates in the Health & Wellness sector.
When did Takeda Pharmaceutical complete a stock split?▼
Takeda Pharmaceutical has not had any recent stock splits.
Where is Takeda Pharmaceutical headquartered?▼
Takeda Pharmaceutical is headquartered in Tokyo, United States.